You have successfully logged out.
Cancer is a complex diagnosis that poses exceptional challenges for patients and medical staff and involves interdisciplinary teams. For oncologists, nurses and pharmacists, cancer treatment has a different focus, but all are committed to improving their patients’ quality of life. By continuously developing smart, innovative solutions and services that simplify and standardize procedures, we contribute to safer therapies. We focus on patients’ needs and involve them into their treatments while protecting health.
Administering chemotherapy does not come without risks. B. Braun is committed to delivering a safer work environment.1 Our solutions for drug application in oncology are developed to help protecting healthcare workers and patients from contamination with cytostatic agents.Strategies to help prevent exposure to cytotoxics
Cancer treatment is emotionally and technically taxing and requires medication management that is efficient and works intuitively. B. Braun is committed to delivering a higher patient safety.2Strategies to help prevent medication errors in administration
Medication management in oncology does not end after the preparation of cytotoxics. It needs an efficient collaboration between the pharmacist, the physician, and the nurse. It also requires traceability along the treatment pathway to identify and to help to avoid medication errors.Strategies to gain traceability along cancer treatment pathways
Optimizing workflows and using closed-system devices can avoid exposure to hazardous drugs thus contributing to the health and safety of all healthcare workers dealing daily with cytotoxics.Strategies to reduce exposure during cytotoxic preparation
The clinical consequences of malnutrition in cancer patients can be higher infection rates, more frequent interruptions of treatment, lower quality of life and longer hospital stays.3
Early diagnostics and treatment of malnutrition in cancer patients can lead to improved health-related quality of life.4Strategies to diagnose and treat malnutrition
 Application study: Conventional infusion devices versus closed system (Cyto-Set®) – risk-reduced and effective preparation and application of chemotherapy. L. Gubelt (KEM I Evang. Kliniken Essen-Mitte gGmbH).
 ONCOSAFETY REMOTE CONTROL®: PATIENT SAFETY AND TREATMENT TRACEABILITY Callado Fortes, S.; Madrid Garzón, D.; Crespo García, I.; Sánchez Molano, M. B.; Martínez García, I.; Lejarcegui Urquiza, U.; Olea Etxebarrieta, L.; Meskaoui Samir, W.; Guinea Vitorica, O.; Espina
Grisaleña, M. B.; Sánchez Tremiño, P.; Barayazarra Echaniz, M.; Echevarria San Martín, S.; Onaindia Arrizabalaga, G.; Montero Matia, R.; Teijeiro Pulido, M. J. Day Hospital - Hospital Galdakao-Usansolo | OSI Barrualde-Galdakao (OSAKIDETZA).
 Santarpia, Lidia, Franco Contaldo, and Fabrizio Pasanisi. Nutritional screening and early treatment of malnutrition in cancer patients. Journal of cachexia, sarcopenia and muscle 2.1 (2011): 27-35.
 Trabal, Joan, et al. Potential usefulness of an EPA-enriched nutritional supplement on chemotherapy tolerability in cancer patients without overt malnutrition. Nutricion hospitalaria 25.5 (2010): 736-740.
 Beirer, A. Malnutrition and cancer, diagnosis and treatment. memo 14, 168-173 (2021)